Remove 2019 Remove Company Remove Development Remove Licensing
article thumbnail

Seattle biotech startup Deverra Therapeutics raising cash to develop cellular immunotherapies

GeekWire

Colleen Delaney, the founder, chief scientific officer, and executive vice president of research and development at Deverra Therapeutics. Fred Hutch Photo) Seattle biotech company Deverra Therapeutics is raising cash for its cellular immunotherapies platform that helps doctors treat patients with cancer and other infectious diseases.

article thumbnail

Six companies dominate network traffic as speed and access grows

TM Forum

In 2021, just six companies – Google, Facebook, Netflix, Amazon, Microsoft and Apple – generated nearly 57% of global network traffic, according to research by Sandvine, a network monitoring company. funding and tax incentives to CSPs developing Open RAN. figures from Reuters. billion euros ($59.4 billion people.

Network 130
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Seattle Children’s spins out BrainChild Bio, a startup developing therapies for incurable brain cancers

GeekWire

The structure opened in downtown Seattle in 2019. The clinical-stage company is launching from Seattle Children’s Therapeutics , an innovation hub within the pediatric hospital. The startup has an exclusive license to use novel CAR T-cell technology developed by Jensen and his team.

article thumbnail

Seattle-based Icosavax, which is developing COVID-19 vaccines, files for IPO 4 years after launch

GeekWire

Icosavax creates virus-like particles with technology licensed from the University of Washington’s Institute for Protein Design. The company, a spin-out from the UW’s Institute for Protein Design , is developing vaccines to resemble naturally occurring viruses. Icosavax Photo). Securities and Exchange Commission.

article thumbnail

Funding news: AI-fueled drug discovery startup and auto safety company raise cash

GeekWire

based company leveraging artificial intelligence to help develop new small molecule drugs, has raised $3.5 The six-employee company has partnerships with an undisclosed public biopharma company, the University of British Columbia, and others. The tech was originally developed to protect military vehicles from missiles.

Company 123
article thumbnail

98point6 hit by new layoffs in latest change at health tech startup

GeekWire

(98point6 Photo) Seattle-based digital healthcare startup 98point6 has conducted a new round of layoffs, the company confirmed Tuesday. Another worker who joined the company more than six years ago called her layoff an “unplanned departure.” ” The company has around 100 employees in the U.S.,

article thumbnail

IBM will no longer offer, develop, or research facial recognition technology

The Verge

The company will also no longer develop or research the technology, IBM tells The Verge. Notably, the NIST’s study did not include technology from Amazon, which is one of the few major tech companies to sell facial recognition software to law enforcement. The company also said that individuals can opt-out of the data set.

IBM 145